WP1066,
857064-38-1,
WP1066,
(S,E)-3-(6-Bromopyridin-2-yl)-2-cyano-N-(1-phenylethyl)acrylamide,
WP 1066,
UNII-63V8AIE65T,
63V8AIE65T,
WP-1066,
C17H14BrN3O,
(E)-3-(6-bromopyridin-2-yl)-2-cyano-N-[(1S)-1-phenylethyl]prop-2-enamide,
AK-99218,
MLS006010178,
GTPL7972,
QCR-16,
SCHEMBL1315826,
SCHEMBL1315831,
CHEMBL1923234,
AOB1497,
DTXSID50235007,
EX-A760,
MFCD12912450,
ZINC13983221,
AKOS016007983,
CS-2736,
DB12679,
WP1066/WP-1066,
2-Propenamide, 3-(6-bromo-2-pyridinyl)-2-cyano-N-((1S)-1-phenylethyl)-, (2E)-,
AC-28413,
AJ-64553,
AS-19242,
BC600373,
HY-15312,
SMR004701286,
BCP0726000087,
AB0032580,
AX8238699,
ST2402908,
S2796,
SW219153-1,
wp1066 pound STAT Inhibitor III pound(c),
X5924,
A11795,
Z-3140,
866409-68-9,
D0IV4C,
cc-685,
VFUAJMPDXIRPKO-LQELWAHVSA-N,
CID11210478,
A4140,
C519885,
WP1066, 98%, a novel inhibitor of JAK2 and STAT3 - 10MG 10mg,